E. Ohman J:Or Asset Management Ab Charles River Laboratories International, Inc. Transaction History

E. Ohman J:Or Asset Management Ab

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Apr 05, 2024	SELL	$197.11 - $250.07 $433,642 - $550,154	-2,200 Closed	0 $0
Q3 2022 Apr 05, 2024	BUY	$182.44 - $250.54 $401,368 - $551,188	2,200 New	2,200 $433 Million
Q1 2022 Apr 05, 2024	SELL	$255.51 - $362.11 $562,122 - $796,642	-2,200 Closed	0 $0
Q3 2021 Apr 05, 2024	BUY	$372.64 - $458.3 $111,792 - $137,490	300 Added 15.79%	2,200 $908 Million
Q2 2021 Apr 05, 2024	BUY	$294.17 - $371.65 $558,923 - $706,135	1,900 New	1,900 $703 Million
Q4 2010 Apr 05, 2024	SELL	N/A	-800 Closed	0 $0
Q4 2007 Apr 05, 2024	BUY	N/A	800	800 $52.6 Million

730

51.8M

233K

236K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.7B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of E. Ohman J:Or Asset Management Ab, based on Form 13F filings with the SEC.

Stay updated on E. Ohman J:Or Asset Management Ab with notifications on news.